Development and evaluation of drugs: from laboratory through licensure to market
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Boca Raton [u.a.]
CRC Press
1993
|
| Schlagworte: | |
| Beschreibung: | 226 S. |
| ISBN: | 0849344476 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV008203745 | ||
| 003 | DE-604 | ||
| 005 | 20130613 | ||
| 007 | t | ||
| 008 | 930907s1993 |||| 00||| eng d | ||
| 020 | |a 0849344476 |9 0-8493-4447-6 | ||
| 035 | |a (OCoLC)27186930 | ||
| 035 | |a (DE-599)BVBBV008203745 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-11 |a DE-188 | ||
| 050 | 0 | |a RM301.25 | |
| 082 | 0 | |a 615/.1/072073 |2 20 | |
| 084 | |a VR 2500 |0 (DE-625)147655: |2 rvk | ||
| 084 | |a VR 5000 |0 (DE-625)147660: |2 rvk | ||
| 084 | |a VS 5360 |0 (DE-625)147688:253 |2 rvk | ||
| 100 | 1 | |a Lee, Chi-Jen |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Development and evaluation of drugs |b from laboratory through licensure to market |c Chi-Jen Lee |
| 264 | 1 | |a Boca Raton [u.a.] |b CRC Press |c 1993 | |
| 300 | |a 226 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 2 | |a Conception de médicaments | |
| 650 | 2 | |a Essais cliniques comme sujet | |
| 650 | 7 | |a Farmaceutische industrie |2 gtt | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Industrie pharmaceutique |2 ram | |
| 650 | 7 | |a Médicaments - Conception |2 ram | |
| 650 | 7 | |a Médicaments - Droit - États-Unis |2 ram | |
| 650 | 7 | |a Médicaments - Essais cliniques |2 ram | |
| 650 | 7 | |a Pharmacie - Recherche |2 ram | |
| 650 | 2 | |a Évaluation médicament | |
| 650 | 4 | |a Recht | |
| 650 | 4 | |a Drug Design |z United States | |
| 650 | 4 | |a Drug Evaluation |z United States | |
| 650 | 4 | |a Drug Industry |z United States | |
| 650 | 4 | |a Drugs |x Law and legislation |z United States | |
| 650 | 4 | |a Drugs |x Research | |
| 650 | 4 | |a Legislation, Pharmacy |z United States | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 0 | 7 | |a Zulassung |0 (DE-588)4127410-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 651 | 4 | |a USA | |
| 651 | 7 | |a USA |0 (DE-588)4078704-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a USA |0 (DE-588)4078704-7 |D g |
| 689 | 1 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 1 | 2 | |a Zulassung |0 (DE-588)4127410-6 |D s |
| 689 | 1 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005413333 | ||
Datensatz im Suchindex
| _version_ | 1804122587737882624 |
|---|---|
| any_adam_object | |
| author | Lee, Chi-Jen |
| author_facet | Lee, Chi-Jen |
| author_role | aut |
| author_sort | Lee, Chi-Jen |
| author_variant | c j l cjl |
| building | Verbundindex |
| bvnumber | BV008203745 |
| callnumber-first | R - Medicine |
| callnumber-label | RM301 |
| callnumber-raw | RM301.25 |
| callnumber-search | RM301.25 |
| callnumber-sort | RM 3301.25 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | VR 2500 VR 5000 VS 5360 |
| ctrlnum | (OCoLC)27186930 (DE-599)BVBBV008203745 |
| dewey-full | 615/.1/072073 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.1/072073 |
| dewey-search | 615/.1/072073 |
| dewey-sort | 3615 11 572073 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02259nam a2200661 c 4500</leader><controlfield tag="001">BV008203745</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130613 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930907s1993 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0849344476</subfield><subfield code="9">0-8493-4447-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)27186930</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008203745</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM301.25</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.1/072073</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VR 2500</subfield><subfield code="0">(DE-625)147655:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VR 5000</subfield><subfield code="0">(DE-625)147660:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5360</subfield><subfield code="0">(DE-625)147688:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lee, Chi-Jen</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development and evaluation of drugs</subfield><subfield code="b">from laboratory through licensure to market</subfield><subfield code="c">Chi-Jen Lee</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton [u.a.]</subfield><subfield code="b">CRC Press</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">226 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Conception de médicaments</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Essais cliniques comme sujet</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Farmaceutische industrie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Industrie pharmaceutique</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Médicaments - Conception</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Médicaments - Droit - États-Unis</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Médicaments - Essais cliniques</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacie - Recherche</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Évaluation médicament</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Legislation, Pharmacy</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">USA</subfield><subfield code="0">(DE-588)4078704-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Zulassung</subfield><subfield code="0">(DE-588)4127410-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005413333</subfield></datafield></record></collection> |
| geographic | USA USA (DE-588)4078704-7 gnd |
| geographic_facet | USA |
| id | DE-604.BV008203745 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T17:16:15Z |
| institution | BVB |
| isbn | 0849344476 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005413333 |
| oclc_num | 27186930 |
| open_access_boolean | |
| owner | DE-12 DE-11 DE-188 |
| owner_facet | DE-12 DE-11 DE-188 |
| physical | 226 S. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | CRC Press |
| record_format | marc |
| spelling | Lee, Chi-Jen Verfasser aut Development and evaluation of drugs from laboratory through licensure to market Chi-Jen Lee Boca Raton [u.a.] CRC Press 1993 226 S. txt rdacontent n rdamedia nc rdacarrier Conception de médicaments Essais cliniques comme sujet Farmaceutische industrie gtt Geneesmiddelen gtt Industrie pharmaceutique ram Médicaments - Conception ram Médicaments - Droit - États-Unis ram Médicaments - Essais cliniques ram Pharmacie - Recherche ram Évaluation médicament Recht Drug Design United States Drug Evaluation United States Drug Industry United States Drugs Law and legislation United States Drugs Research Legislation, Pharmacy United States Pharmaceutical industry Zulassung (DE-588)4127410-6 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf USA USA (DE-588)4078704-7 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 USA (DE-588)4078704-7 g Arzneimittel (DE-588)4003115-9 s Zulassung (DE-588)4127410-6 s |
| spellingShingle | Lee, Chi-Jen Development and evaluation of drugs from laboratory through licensure to market Conception de médicaments Essais cliniques comme sujet Farmaceutische industrie gtt Geneesmiddelen gtt Industrie pharmaceutique ram Médicaments - Conception ram Médicaments - Droit - États-Unis ram Médicaments - Essais cliniques ram Pharmacie - Recherche ram Évaluation médicament Recht Drug Design United States Drug Evaluation United States Drug Industry United States Drugs Law and legislation United States Drugs Research Legislation, Pharmacy United States Pharmaceutical industry Zulassung (DE-588)4127410-6 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
| subject_GND | (DE-588)4127410-6 (DE-588)4143176-5 (DE-588)4003115-9 (DE-588)4078704-7 |
| title | Development and evaluation of drugs from laboratory through licensure to market |
| title_auth | Development and evaluation of drugs from laboratory through licensure to market |
| title_exact_search | Development and evaluation of drugs from laboratory through licensure to market |
| title_full | Development and evaluation of drugs from laboratory through licensure to market Chi-Jen Lee |
| title_fullStr | Development and evaluation of drugs from laboratory through licensure to market Chi-Jen Lee |
| title_full_unstemmed | Development and evaluation of drugs from laboratory through licensure to market Chi-Jen Lee |
| title_short | Development and evaluation of drugs |
| title_sort | development and evaluation of drugs from laboratory through licensure to market |
| title_sub | from laboratory through licensure to market |
| topic | Conception de médicaments Essais cliniques comme sujet Farmaceutische industrie gtt Geneesmiddelen gtt Industrie pharmaceutique ram Médicaments - Conception ram Médicaments - Droit - États-Unis ram Médicaments - Essais cliniques ram Pharmacie - Recherche ram Évaluation médicament Recht Drug Design United States Drug Evaluation United States Drug Industry United States Drugs Law and legislation United States Drugs Research Legislation, Pharmacy United States Pharmaceutical industry Zulassung (DE-588)4127410-6 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittel (DE-588)4003115-9 gnd |
| topic_facet | Conception de médicaments Essais cliniques comme sujet Farmaceutische industrie Geneesmiddelen Industrie pharmaceutique Médicaments - Conception Médicaments - Droit - États-Unis Médicaments - Essais cliniques Pharmacie - Recherche Évaluation médicament Recht Drug Design United States Drug Evaluation United States Drug Industry United States Drugs Law and legislation United States Drugs Research Legislation, Pharmacy United States Pharmaceutical industry Zulassung Arzneimittelentwicklung Arzneimittel USA |
| work_keys_str_mv | AT leechijen developmentandevaluationofdrugsfromlaboratorythroughlicensuretomarket |